PEG-MGF 2mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only – not for human or veterinary use.

Product Overview
PEG-MGF is a synthetic research peptide supplied exclusively for controlled laboratory and in-vitro research purposes. This 2 mg lyophilized peptide is intended for analytical evaluation of modified peptide structures, molecular stability and signalling behaviour within experimental laboratory systems.

Peptide Overview
PEG-MGF is a pegylated analogue of mechano growth factor, developed to study peptide modification techniques such as polyethylene glycol conjugation and their influence on peptide stability and structural persistence. Scientific research interest in pegylated peptides expanded notably between 2000 and 2025 as laboratories investigated extended peptide stability and altered molecular interaction profiles in experimental models.

Historical Background and Scientific Context
Research into growth factor–related peptide fragments began in the late 1980s, with further development during the 1990s as synthetic peptide engineering advanced. From the early 2000s onward, pegylation techniques became increasingly important in laboratory research, allowing scientists to explore extended peptide stability, altered degradation rates and controlled signalling behaviour in in-vitro systems. Between 2010 and 2025, PEG-MGF became a commonly referenced research compound in studies examining modified peptide structures.

Structural & Molecular Characteristics
• Peptide classification: synthetic pegylated peptide analogue
• Molecular structure: modified linear peptide sequence with PEG conjugation
• Form: lyophilized peptide powder
• Intended use: controlled laboratory and in-vitro research

Mechanistic Focus in Research

• Peptide modification and pegylation studies
• Structural stability and degradation profiling
• Comparative analysis of modified peptide analogues
• Signalling pathway evaluation in laboratory systems
• Controlled in-vitro biochemical experimentation

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• PEG-MGF synthetic research peptide
• Guaranteed purity level exceeds 99 %
• Lyophilized peptide for laboratory research
• Produced under strict quality standards
• Suitable for controlled in-vitro research applications
• Sealed vial with batch traceability
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.